跳至主要内容
临床试验/NCT03078504
NCT03078504终止不适用

Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy

St. Louis University2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2017年2月17日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
6
试验地点
2
主要终点
Blood Pressure Change

研究概览

简要总结

Purpose of this study is to evaluate the short-term hemodynamic effects of changes in blood flow rates in critically ill patients receiving continuous renal replacement therapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-89
  • Acute renal failure or end-stage renal disease necessitating CRRT
  • Admitted to the MICU service
  • If on vasopressor/inotropic agent, norepinephrine as only intravenous pressor
  • If on vasopressor/inotropic agent, at stable pressor dose for at least four hours
  • If on IV fluids, stable dose of crystalloids <= 100cc/hour and is not receiving colloids for 4 hours or more prior to initiation of CRRT
  • Mean arterial pressure (MAP) >= 65
  • Arterial catheter present for continuous blood pressure monitoring
  • CRRT duration of 48 hours or less using NxStage System One dialysis system
  • successfully tolerated CRRT for at least 4 hours without clotting or hemodynamic instability
  • no other procedures, blood products transfusion, or additional medication administration are anticipated during the study period

排除标准

  • listed for organ transplant
  • atrial fibrillation, other irregular heart rhythm, unstable arrhythmia
  • need for more than one intravenous vasopressor agent
  • intravenous vasopressor/inotropic agent other than norepinephrine (ie dobutamine, dopamine, vasopressin, epinephrine)
  • therapeutic anticoagulation being administered
  • known acute myocardial infarction as defined by elevated troponin along with a documented clinical diagnosis during current hospitalization
  • known acute stroke, intracerebral hemorrhage, intracranial mass effect, or elevated intracranial pressure within the last 30 days.
  • dialysis catheter malfunction and unable to maintain target blood flow rate
  • fluid removal (ultrafiltration) rate > 100mL/hour

结局指标

主要结局

Blood Pressure Change

时间窗: 10 minutes

Change in mean arterial pressure from period 1 to period 2

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zafar Jamkhana, MD

Associate Professor

St. Louis University

研究点 (2)

Loading locations...

相似试验